®
PRESS COVERAGE
May 13, 2026
Pitt-Founded Startup Achieves First-in-Human Implant of Nerve Pain Device
A medical device startup founded by University of Pittsburgh Swanson School of Engineering researchers has implanted its first human patient as part of an FDA-approved clinical study, marking a major step toward commercialization of a technology designed to prevent chronic nerve pain.
PRESS COVERAGE
May 13, 2026
Renerva Achieves First-in-Human Implant of PNM-CAP™ Device for Neuroma Pain
Renerva, Inc., a medical device company developing solutions for peripheral nerve injuries, today announced the implantation of the first patient in its first-in-human clinical study of the Renerva PNM-CAP™ device.
PRESS COVERAGE
Dec 3, 2025
Renerva Inc. approved for first-in-human FDA clinical trials
More than two million people in the U.S. are amputees, and an estimated 500,000 new extremity amputations occur each year because of trauma, disease, or surgical complications. Offering new hope, however, a medical device startup from the University of Pittsburgh has just reached a major milestone to improve care for individuals living with extremity amputations and other conditions causing nerve injury.
PRESS COVERAGE
Dec 3, 2025
Renerva Receives FDA IDE Approval to Commence First-in-Human Study of its Renerva PNM-CAP™ Device for Neuroma Pain
Renerva, Inc., a medical device company developing solutions for peripheral nerve repair, today announced it has received Investigational Device Exemption (IDE) approval from the U.S. Food and Drug Administration (FDA) to initiate a first-in-human (FIH) clinical study for its Renerva PNM-CAP™ device.